Upcoming events

Stable CAD (Coronary artery disease)

Here you will find all the latest content on stable coronary artery disease (stable CAD) published on this website. Results are listed in chronological order.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

228 results

How intravascular imaging can optimise PCI results

11 Jul 2017 - From EUROPCR 2017

Complex PCI, STEMI...does using IVUS really reduce major adverse cardiovascular events? Join C. Cook, Z. Ali and G. Guagliumi as they review the proper way to use this “irrefutable” imaging tool. Does IVUS have a role throughout a procedure? How should you prepare and map your strategy in advance? Leanr why they characterise this as “the essence of decision–making”? What does the future hold in store for these technologies? How can we move to more “objective” measurements? What is the importance of the upcoming trial comparing high-risk patients and high-risk lesion randomised to angiography against OCT? Learn more here…

Management of patients with multilevel atherosclerosis

11 Jul 2017 - From EUROPCR 2017

While we are used to treating coronary artery disease, interventional cardiologists need to keep in mind that many of these patients have a silent form of vascular involvement because of atherosclerosis. S. Redwood, F. Ribichini and M. Roffi focus on this complex topic and the implications of taking charge of patients with diffuse disease. What current evidence exists in this often older and sicker population? On what level should management begin? Why is the best treatment one that is provided by a clinician working with a team of dedicated specialists in a “patient-centred” approach? Learn the details here…

LIVE case: CAD in TAVI patient

From EUROPCR 2017

Consult this LIVE case on CAD in TAVI patient, an 87-year-old female patient with CAD and aortic stenosis that include a LIVE demonstration from Saint Thomas' Hospital, London.

Clinical case

A 87-year-old female with CAD and aortic stenosis:

Randomised to ACTIVATION trialSimplified TAVISapien 3 implanted
Dr Bernard Prendergast


Bernard Prendergast
Dr. Simon Redwood


Simon Redwood
Jane Hancock


Jane Hancock

EuroPCR 2017 Highlights: Coronary Interventions

20 May 2017 - From EUROPCR 2017

From the standpoint of 40 years of angioplasty, 20 years of physiological assessment and emerging data on a variety of topics, J. Byrne and T. Johnson review data published at EuroPCR 2017. Interest remains intense concerning bioresorbable stents (BRS) with ongoing international trials and whether evolving new devices and techniques will answer the problem of thrombosis. Complex interventions such as CTO showed interesting data and the evolution in our use of iFR or FFR continues to demonstrate the role innovation plays in our specialty, hereby better understanding physiology to improve treatment strategies and positively impacting outcome.

Will PIONEER AF-PCI change my practice?

19 May 2017

EuroPCR 2017: Fresh data on OCT management, FFR guidance and bioresorbable stents

Participants saw exciting results from a number of late-breaking trials during EuroPCR 2017, focusing on such topics as chronic total occlusions (CTO), neurological outcomes following TAVI in intermediate-risk patients, and bioresorbable vs. bare metal stents.

New frontiers for coronay physiology

18 May 2017

Antiplatelet regimen after PCI: an ongoing debate

18 May 2017

All you need to know about coronary physiology in 2017

18 May 2017

An image is worth 1,000 words

18 May 2017